In the IIH: Pressure RCT, both exenatide and placebo groups had normal baseline acuity
Probiotics may support gut health, though evidence for their efficacy in medication-induced gastrointestinal symptoms remains limited
Pastar I, Stojadinovic O, Yin NC, et al
Nagel, Jonas Binder, Michael Sztucki, Wolfgang Friess, Tim Menzen, Gerhard Winter, Evgenyi Shalaev #Pharmaceuticals #ProteinStability #FreezeDrying #SAXS #Biophysics #OpenScience To view or add a comment, sign in In the phase 3 ACHIEVE clinical trial, Eli Lilly's orforglipron (an oral glucagon-like peptide 1 [GLP-1] receptor agonist) outperformed semaglutide in lowering A1C levels and promoting weight loss over 52 weeks
Theranostic nanomedicine in the NIR-II window: classification, fabrication, and biomedical applications